Shenaz Bagha

WASHINGTON — Pain in patients scheduled for total knee arthroplasty demonstrates no relation to physical activity, suggesting pain relief alone may

WASHINGTON — Rising rates of ACR20 response in the placebo arms of rheumatoid arthritis trials may be related to increasingly globalized recruitment patterns, according to data presented at ACR Convergence 2024.

WASHINGTON — High rates of premature mortality from rheumatoid arthritis among Native American populations have seen no change in the past 20 years, while other races have demonstrated improving trends, according to data. “Many people with rheumatoid arthritis die at younger ages from cardiovascular, respiratory, cancer and infectious causes,” Parmita Das, of the University of

The field of rheumatology has “left behind” patients with lupus from Africa — and across the global African diaspora — at nearly all academic and

Video Player is loading. Play Video Play Mute Current Time Duration Loaded

For individuals with recent acute cervical spinal cord injuries, treatment with a novel neuroregenerative therapeutic was nonsuperior to placebo after 6 months, according to research published in The Lancet Neurology

We are again privileged to have rheumatologist and author Chuck Radis, DO, grace the pages of Healio Rheumatology with his continuing observations

I have just returned and am recovering from #ACR24, and although there is a universe of things happening in our field, I want to focus for a moment

WASHINGTON — Patients with lupus and type 2 diabetes who receive glucagon-like peptide-1 receptor agonists demonstrate a lower risk for cardiac

BOSTON — A study in Honduras shows food sensitization is common among children there, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.